NLNK - NewLink shareholders back Lumos merger March, 18 2020 08:16 AM NewLink Genetics NewLink Genetics (NASDAQ:NLNK) shareholders have voted overwhelmingly in favor of its previously announced merger with Lumos Pharma.More news on: NewLink Genetics Corporation, Healthcare stocks news, Merger & acquisition news, Read more ...